Patients who qualify for IOV-LUN-202 meet the following criteria:
- They have received systemic therapy that included immunotherapy and chemotherapy with documented radiographic disease progression
- LVEF >45%, NYHA Class 1
- FEV1 >50% or FEV1/FVC >0.7
- At least 1 resectable lesion and 1 remaining measurable lesion
- ECOG performance status of 0 or 1
ECOG, Eastern Cooperative Oncology Group; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.